Interní Med. 2011; 13(1): 18-19

Exacerbation of chronic obstructive pulmonary disease

MUDr.Vladimír Herout
Plicní klinika LF UK a FN Hradec Králové

Course of the chronic obstructive pulmonary disease (COPD) may be complicated by period of deterioration, which is called exacerbation.

Every exacerbation should be defined and treated adequately. Prevention has the same importance as treatment.

Keywords: chronic obstructive pulmonary disease, acute exacerbation, respiratory failure, noninvasive ventilation

Published: January 14, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Herout V. Exacerbation of chronic obstructive pulmonary disease. Interní Med. 2011;13(1):18-19.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Revised 2007. Aviable from: www.goldcopd.org.
    2. Kašák V, Koblížek V. Exacerbace chronické obstrukční plicní nemoci. In: Naléhavé stavy v pneumologii. Maxdorf Praha 2008: 250-275.
    3. Urbášková P. Surveillance rezistence k antibiotikům u nejčastějších bakteriálních původců respiračních infekcí v České republice. Remedia 2000; 10: 195-203.
    4. Musil J. Diagnostika a léčba exacerbace chronické obstrukční plicní nemoci (CHOPN). Practicus 2009; 2: 18.
    5. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329(7476): 1209. Go to original source... Go to PubMed...
    6. Calverley PMA, Pauwels R, Vesbo J, et al. Combined salmeterol and fluticason in the treatment of chronic obstructive lung disease: a randomised controlled trial. Lancet 2003; 361: 449-456. Go to original source... Go to PubMed...
    7. Calverley PMA, Boonsawat W, Czeke Z, et al. Maintenance therapy with budesonid and formoterol in chronic obstructive pulmonary disease. Eur respir J. 2003; 22: 912-919. Go to original source... Go to PubMed...
    8. Yael W, Roflumilast Approved in Europe for Chronic Obstructive Pulmonary Disease, Medscape today, at: http://www.medscape.com/viewarticle/724903.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.